281 related articles for article (PubMed ID: 10629657)
1. Second malignancies after a gastrectomy for gastric cancers: the effects of adjuvant therapies.
Nio Y; Hirahara N; Minari Y; Sasaki S; Takamura M; Sato Y; Inoue Y; Nagami H; Tamura K
Anticancer Res; 1999; 19(4C):3591-9. PubMed ID: 10629657
[TBL] [Abstract][Full Text] [Related]
2. [Second malignancy after gastrectomy for early gastric cancer-is there any evidence that adjuvant chemotherapy for early gastric cancer causes a second malignancy ?].
Honda I; Kobayashi D; Fukumoto R; Matsushita H; Hattori M; Nagata M; Watanabe S
Gan To Kagaku Ryoho; 2008 Aug; 35(8):1341-5. PubMed ID: 18701845
[TBL] [Abstract][Full Text] [Related]
3. [Second primary malignancy after surgical adjuvant therapy for gastric cancer].
Fujimoto J
Gan To Kagaku Ryoho; 1999 Nov; 26(13):2009-14. PubMed ID: 10584564
[TBL] [Abstract][Full Text] [Related]
4. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
5. Synchronous and metachronous primary malignancies in organs other than the stomach in patients with early gastric cancer.
Ikeguchi M; Ohfuji S; Oka A; Tsujitani S; Maeda M; Kaibara N
Hepatogastroenterology; 1995; 42(5):672-6. PubMed ID: 8751233
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer.
Chipponi J; Huguier M; Pezet D; Basso N; Hay JM; Quandalle P; Jaeck D; Fagniez PL; Gainant A
Am J Surg; 2004 Mar; 187(3):440-5. PubMed ID: 15006580
[TBL] [Abstract][Full Text] [Related]
7. Role of surgery in the patients with stage I and II primary gastric lymphoma.
Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
[TBL] [Abstract][Full Text] [Related]
9. [Secondary malignancies after gastrectomy for gastric cancer].
Niimoto M; Hirono M; Hattori T; Nakajima T; Hirata K; Iwanaga T; Kimura T; Nakazato H; Inokuchi K; Sugimachi K
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1475-83. PubMed ID: 3729464
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01.
Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N
J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384
[TBL] [Abstract][Full Text] [Related]
11. Treatments for second malignancies after gastrectomy for stomach cancer.
Furukawa H; Hiratsuka M; Iwanaga T; Imaoka S; Kabuto T; Ishikawa O; Sasaki Y; Kameyama M; Ohigashi H; Nakamori S
Hepatogastroenterology; 1996; 43(7):194-8. PubMed ID: 8682461
[TBL] [Abstract][Full Text] [Related]
12. Survival of gastric cancer with concomitant liver metastases.
Kwok CM; Wu CW; Lo SS; Shen KH; Hsieh MC; Lui WY
Hepatogastroenterology; 2004; 51(59):1527-30. PubMed ID: 15362793
[TBL] [Abstract][Full Text] [Related]
13. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
[TBL] [Abstract][Full Text] [Related]
14. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
[TBL] [Abstract][Full Text] [Related]
15. Clinical profile of carcinoma stomach at a tertiary care hospital in south India.
Sambasivaiah K; Ibrarullah M; Reddy MK; Reddy PV; Wagholikar G; Jaiman S; Reddy DG; Sarma KV; Hegde GN
Trop Gastroenterol; 2004; 25(1):21-6. PubMed ID: 15303466
[TBL] [Abstract][Full Text] [Related]
16. [Utilization of multimodal therapy concepts in stomach carcinoma in Germany].
Bösing NM; Heise JW; Röher HD
Zentralbl Chir; 2000; 125(4):341-7. PubMed ID: 10829314
[TBL] [Abstract][Full Text] [Related]
17. Results of immunochemo-surgery for gastric carcinoma.
Kim JP; Yu HJ; Lee JH
Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
[TBL] [Abstract][Full Text] [Related]
18. Risk of second primary malignancy after esophagectomy for squamous cell carcinoma of the thoracic esophagus.
Matsubara T; Yamada K; Nakagawa A
J Clin Oncol; 2003 Dec; 21(23):4336-41. PubMed ID: 14645422
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
20. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
